Icariside II activates EGFR-Akt-Nrf2 signaling and protects osteoblasts from dexamethasone

MLA

Feng-Li Chen, et al. “Icariside II Activates EGFR-Akt-Nrf2 Signaling and Protects Osteoblasts from Dexamethasone.” Oncotarget, vol. 8, no. 2, Dec. 2016, pp. 2594–603. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....5e27dd63bf1cce9b4caee8552f29b00a&authtype=sso&custid=ns315887.

APA

Feng-Li Chen, Shouguo Wang, Feng Ji, Weidong Liu, Li Mao, & Yue Xie. (2016). Icariside II activates EGFR-Akt-Nrf2 signaling and protects osteoblasts from dexamethasone. Oncotarget, 8(2), 2594–2603.

Chicago

Feng-Li Chen, Shouguo Wang, Feng Ji, Weidong Liu, Li Mao, and Yue Xie. 2016. “Icariside II Activates EGFR-Akt-Nrf2 Signaling and Protects Osteoblasts from Dexamethasone.” Oncotarget 8 (2): 2594–2603. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....5e27dd63bf1cce9b4caee8552f29b00a&authtype=sso&custid=ns315887.